Jonathan G Drachman
Insider
First SEC filing: Feb. 14, 2022 · Latest: Feb. 14, 2022
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net: $0
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Aug. 2, 2022 | NGNE | A | 350,000 | · | · | 350,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 25, 2021 | NGNE | P | 25,000 | $6.45 | $161,250 | 25,000 Indirect | · | Acquired | -80.5% (price as of 2026-10-05) |
| Aug. 25, 2021 | NGNE | P | 25,000 | $6.45 | $161,250 | 25,000 Indirect | · | Acquired | -80.5% (price as of 2026-10-05) |
| Aug. 24, 2021 | NGNE | P | 100,000 | $6.11 | $611,000 | 2,348,686 Direct | +4.45% | Acquired | -79.4% (price as of 2026-10-05) |
| Aug. 3, 2021 | NGNE | A | 400,000 | · | · | 400,000 Direct | · | Acquired | (price as of 2026-10-05) |
| June 4, 2021 | NGNE | P | 10,000 | $9.61 | $96,100 | 2,248,686 Direct | +0.45% | Acquired | -86.9% (price as of 2026-10-05) |
| June 3, 2021 | NGNE | P | 40,000 | $9.48 | $379,200 | 2,238,686 Direct | +1.82% | Acquired | -86.7% (price as of 2026-10-05) |
| Aug. 10, 2020 | NGNE | A | 420,000 | · | · | 420,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Dec. 20, 2019 | NGNE | P | 119,047 | $8.40 | $999,995 | 2,198,686 Direct | +5.72% | Acquired | -85.0% (price as of 2026-10-05) |
| Nov. 12, 2019 | NGNE | C | 1,261,600 | · | · | 2,079,639 Direct | +154.22% | Acquired | (price as of 2026-10-05) |
| Nov. 12, 2019 | NGNE | C | 12,616 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-05) |
| Sept. 11, 2019 | NGNE | P | 136,436 | $3.30 | $450,239 | 584,428 Direct | +30.46% | Acquired | -61.9% (price as of 2026-10-05) |
| Sept. 10, 2019 | NGNE | P | 36,742 | $3.08 | $113,165 | 447,992 Direct | +8.93% | Acquired | -59.1% (price as of 2026-10-05) |
| Sept. 9, 2019 | NGNE | P | 76,822 | $2.84 | $218,174 | 411,250 Direct | +22.97% | Acquired | -55.7% (price as of 2026-10-05) |
| Aug. 31, 2019 | NGNE | A | 1,650,000 | · | · | 1,650,000 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2019 | NGNE | A | 12,616 | · | · | 12,616 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2019 | NGNE | A | 568,039 | · | · | 568,039 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2019 | NGNE | A | 7,428 | · | · | 7,428 Direct | · | Acquired | (price as of 2026-10-05) |
| Aug. 8, 2019 | NGNE | A | 334,428 | · | · | 334,428 Direct | · | Acquired | (price as of 2026-10-05) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 2, 2022 | NGNE | Stock Option (Right to Buy) | Common Stock | $0.99 | Aug. 1, 2032 | 350,000 | Acquired |
| Aug. 3, 2021 | NGNE | Stock Option (Right to Buy) | Common Stock | $6.80 | Aug. 3, 2031 | 400,000 | Acquired |
| Aug. 10, 2020 | NGNE | Stock Option (Right to Buy) | Common Stock | $12.00 | Aug. 10, 2030 | 420,000 | Acquired |
| Aug. 31, 2019 | NGNE | Stock Option (Right to Buy) | Common Stock | $2.80 | Aug. 31, 2029 | 1,650,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $113,544 | · | · | · | · | · | $436,439 | $549,983 |
| 2021 | $438,640 | · | · | · | $208,354 | · | $4,300 | $2,650,131 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.